Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 21Unknown 8Recruiting 7Withdrawn 2Terminated 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 437Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 174Colorectal Neoplasms 156Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 130Lymphoma 127Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Brain Neoplasms 101Recurrence 100Head and Neck Neoplasms 100Leukemia, Lymphocytic, Chronic, B-Cell 96Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 74Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

Indocyanine Green 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Neuroma × Clear all
NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡